Pharmafile Logo
Pharmafocus logo
Advanced Search

New ABPI president appointed

April 30, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, MSD UK, appointment

Deepak Khanna, senior vice president and MSD UK managing director, has been appointed as President of the Association of the …

Appointment
FDA picture

FDA approves new erectile dysfunction drug

April 30, 2012
Sales and Marketing ED, FDA, Stendra. Pfizer, Vivus, viagra

The FDA has approved Vivus’ erectile dysfunction drug Stendra, and the firm hopes its rapid mode of action will help …

News
Benlysta image

NICE no to GSK’s lupus drug Benlysta

April 27, 2012
Sales and Marketing Andrew Dillon, Benlysta, GSK, Lupus, NICE

NICE is still not recommending GlaxoSmithKline’s lupus drug Benlysta, as it believes the treatment is too costly.  In its final …

News
screen_shot_2012-04-27_at_10

Novartis right to challenge NHS on Avastin use – ABPI chief

April 27, 2012
Sales and Marketing ABPI, Lucentis, Whitehead, avastin, wet AMD

The ABPI has declared its support for Novartis in its legal challenge against off-label prescribing in England.The pharma company is …

News

New head at Bayer’s Animal Health division

April 27, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer Healthcare, Dirk Ehle, animal health

Dr Dirk Ehle has been appointed Head of the Animal Health Division of Bayer.  The 42-year-old succeeds Dr Jean-Luc Lowinski, …

Appointment

Watson buys Actavis to create generics giant

April 27, 2012
Sales and Marketing Actavis, Watson, generics

Watson Pharmaceuticals is to buy rival Actavis Group in a move that will create the third largest generics manufacturer in …

News

Brennan bows to pressure and quits AstraZeneca

April 26, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, David Brennan, Q1, pharma

AstraZeneca’s chief executive David Brennan is to step down from his post following mounting dissatisfaction with his leadership. Brennan, who …

News

Novartis Q1 earnings slide down

April 26, 2012
Sales and Marketing Novartis, Q1, Sandoz, generics, gilenya

Generic competition and problems at a US plant were among the reasons why Novartis’ sales and profit dipped in the …

News
Texting image

Text message prompts ‘improve medicines adherence’

April 26, 2012
Medical Communications SMS, Text messages, digital communications, medicines adherence

Patients with long-term diseases benefit from having text message reminders to take their medication.  This is according to a new …

News
Victrelis picture

Two new hep C pills recommended by NICE

April 25, 2012
Sales and Marketing Incivo, Janssen, MSD, NICE, Victrelis, hep C

NICE has given its final recommendation for two new hepatitis C pills in an expedited review.  Janssen’s Incivo (telaprevir) and …

News
Boehringer Ingelheim image

A family business: Pradaxa success lifts Boehringer

April 25, 2012
Research and Development, Sales and Marketing Boehringer Ingelheim

Rapid uptake of anti-clotting drug Pradaxa in the US has helped Boehringer Ingelheim enjoy a strong year, and looks set to …

Feature

GMC won’t relax off-label prescribing guidelines

April 25, 2012
Sales and Marketing GMC, Lucentis, Novartis, Roche, avastin, off label, off-label

The GMC has decided not to relax guidelines on off-label prescribing when a licensed alternative exists. The GMC’s current rules …

News
paul_mannu

Paul Mannu joins Insight Research Group as consultant

April 25, 2012
Business Services, Medical Communications, Sales and Marketing Cello, Insight Research Group

Paul Mannu has joined the senior research team at Insight Research Group as a consultant. For the last few years Paul …

Appointment

Merck KGaA swings axe over Serono operations

April 25, 2012
Manufacturing and Production, Research and Development, Sales and Marketing Cladribine, MS, Merck KGaA, Switzerland, job cuts

Merck KGaA will cut around 500 jobs from its pharmaceutical unit in Switzerland, the firm has announced.  The company said …

News
Herceptin image

New data shows Herceptin’s ability to increase survival

April 24, 2012
Research and Development, Sales and Marketing Cancer, Cochrane, Herceptin, Roche, breast

A new review of Roche’s breast cancer drug Herceptin has confirmed its ability to increase overall survival, but concerns remain …

News
Shire's Vpriv website

Shire’s Vpriv website in breach of ABPI Code

April 24, 2012
Medical Communications, Sales and Marketing ABPI, Genzyme, PMCPA, Shire, Vpriv, code

Shire’s website for its Gaucher’s disease drug Vpriv has fallen foul of the ABPI’s Code of Conduct.  The complaint was …

News
Novartis image

Novartis to invest $550m in new Swiss plant

April 24, 2012
Manufacturing and Production GSK, Novartis, manufacturing and production

Novartis has unveiled plans to build a new manufacturing facility at its site in Stein, Switzerland, just weeks after calling …

News

7 steps to better talent acquisition

April 24, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, Talent acquisition, careers, executives

When companies complain that they can’t find enough good people, the cause, in our view, is most likely to be …

Feature
Lucentis image

Charity challenges government on Avastin for wet AMD

April 24, 2012
Sales and Marketing Lucentis, Novartis, Roche, avastin, off label, off-label, wet AMD

A leading patient group has called on the government to get to grips with the issue of off-label prescribing, as …

News
tom_pike_500_pixels_wide_-_quintiles

Quintiles appoints Tom Pike as new chief executive

April 24, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Quintiles, Tom Pike, biopharmaceutical

Quintiles, the biopharmaceutical services company, has appointed Tom Pike as its new chief executive, effective from 30 April. The appointment …

Appointment
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026